Related Experiment Video
Updated: Jul 3, 2026
08:27
Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens.
Brody Pullinger1, Nichaela Harbison-Price1, Ismail Sebina2
1Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Clinical Microbiology Reviews
|July 2, 2026
Summary
Messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccines show promise against viruses and cancer. However, developing these advanced vaccines against bacterial pathogens faces unique challenges, requiring further research.
Area of Science:
- Vaccinology
- Infectious Disease Research
- Biotechnology
Background:
- Messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccines have emerged as a significant advancement in vaccinology.
- Recent studies since 2020 highlight their proven efficacy against viral infections and cancer.
- Development of mRNA-LNP vaccines for bacterial pathogens remains limited due to specific challenges.
Purpose of the Study:
- To review the challenges in developing mRNA-LNP vaccines against bacterial pathogens.
- To outline the potential advantages of using the mRNA-LNP platform for bacterial vaccines.
- To summarize the current progress in creating mRNA-LNP vaccines for bacterial infections.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of challenges specific to bacterial vaccine development.
- Evaluation of the mRNA-LNP platform's applicability to bacterial targets.
Main Results:
- Significant hurdles exist in adapting mRNA-LNP technology for bacterial vaccine applications.
- The mRNA-LNP platform offers unique benefits for bacterial vaccine design.
- Progress is being made, but substantial research is still needed.
Conclusions:
- Overcoming bacterial vaccine-specific challenges is crucial for mRNA-LNP platform expansion.
- Further investigation is required to fully realize the potential of mRNA-LNP vaccines against bacterial diseases.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...